JAVIER DE LAS
RIVAS SANZ
Investigador
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (5)
2020
-
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Drug Resistance Updates, Vol. 53
2011
-
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival
Cancer Biomarkers, Vol. 10, Núm. 1, pp. 35-41
2009
-
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
Clinical Cancer Research, Vol. 15, Núm. 16, pp. 5082-5091
2008
-
Interleukin-12 inhibits liver-specific drug-inducible systems in vivo
Gene Therapy, Vol. 15, Núm. 4, pp. 277-288
-
Transcriptomic effects of Tet-on and mifepristone-inducible systems in mouse liver
Human Gene Therapy, Vol. 19, Núm. 11, pp. 1233-1247